Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Retained Earnings (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of Retained Earnings data on record, last reported at -$854.1 million in Q3 2025.

  • For Q3 2025, Retained Earnings fell 547423.72% year-over-year to -$854.1 million; the TTM value through Sep 2025 reached -$854.1 million, down 547423.72%, while the annual FY2024 figure was -$211000.0, 160.49% down from the prior year.
  • Retained Earnings reached -$854.1 million in Q3 2025 per ASMB's latest filing, down from -$844.9 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$81000.0 in Q4 2023 and bottomed at -$854.1 million in Q3 2025.
  • Average Retained Earnings over 5 years is -$414.9 million, with a median of -$571.2 million recorded in 2021.
  • Peak YoY movement for Retained Earnings: surged 99.99% in 2023, then crashed 547423.72% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$419000.0 in 2021, then crashed by 172816.47% to -$724.5 million in 2022, then soared by 99.99% to -$81000.0 in 2023, then crashed by 160.49% to -$211000.0 in 2024, then tumbled by 404704.27% to -$854.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$854.1 million in Q3 2025, -$844.9 million in Q2 2025, and -$253000.0 in Q1 2025.